(-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury

Journal of Neuroscience Research

Volumn 78, Issue 5, 2004, Pages 723-731

  Li, Rui ^a,b,c   Huang, Yuan Gui ^c   Fang, Du ^a,b,c   Le, Wei Dong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Green tea polyphenol; Nitric oxide; Parkinson disease; Tumor necrosis factor; Tyrosine hydroxylase

Indexed keywords

EPIGALLOCATECHIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; POLYPHENOL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL LINE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MICROGLIA; NERVE CELL DEGENERATION; NERVE INJURY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TEA; TUMOR CELL CULTURE;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; BLOTTING, WESTERN; CARBOCYANINES; CATECHIN; CELL COUNT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICROGLIA; MICROTUBULE-ASSOCIATED PROTEINS; NEUROBLASTOMA; NEURONS; NITRIC OXIDE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE 3-MONOOXYGENASE;

EID: 10644230076     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20315     Document Type: Article

References (43)

1. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC. 2001. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 50:56-63.
2. Barron KD. 1995. The microglial cell. A historical review. J Neurol Sci 134:57-68.
3. Calixto JB, Campos MM, Otuki MF, Santos AR. 2004. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 70:93-103.
4. Chan DK, Woo J, Ho SC. 1998. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 65:781-784.
5. Chen SD, Le WD, Xie WJ, Alexianu ME, Engelhardt JI, Siklos L, Appel SH. 1998. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch Neurol 55:1075-1080.
6. Choi YT, Jung CH, Lee SR, Bae JH, Baek WK, Suh MH, Park J, Park CW, Suh SI. 2001. The green tea polyphenol (-)-epigallocatechin gallate attenuate beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci 70:603-614.
7. Crawford GD, Le WD, Smith RG, Xie W, Stefani E, Appel SH. 1992. A novel N18TG2 mesencephalon cell hybrid expresses properties which suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 12:3392-3398.
8. Czlonkowska A, Kohutnicka M, Kurkowska-Jastrzebska I, Czlonkowski A. 1996. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration 5:137-143.
9. Delgado M, Ganea D. 2003. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation. FASEB J 17:944-946.
10. Gao HM, Jiang J, Wilson B, Zhang WQ, Hong JS, Liu B. 2002. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 81:1285-1297.
11. Giulian D, Baker TJ. 1986. Characterization of ameboid microglia isolated from developing mamalian brain. J Neurosci 6:2163-2178.
12. Hertog M, Feskens E, Kromhout D. 1997. Antioxidant flavonols and coronary heart disease risk. Lancet 349:699.
13. Hunot S, Boissiere F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC. 1996. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72:355-363.
14. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS. 1998. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron-glia cultures. J Neuroimmunol 85:1-10.
15. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. 2000. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309-6316.
16. Le WD, Rowe D, Xie W, Ortiz I, He Y, Appel SH. 2001. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci 21:8447-8455.
17. Lee S, Suh S, Kim S. 2000. Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 287:191-194.
18. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S. 2001. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78:1073-1082.
19. Levites Y, Youdim MB, Maor G, Mandel S. 2002. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-κB (NF-κB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63:21-29.
20. Lin YL, Lin JK. 1997. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol 52:465-472.
21. Liu Y, Qin L, Li G, Zhang W, An L, Liu B, Hong JS. 2003. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J Pharmacol Exp Ther 305:212-221.
22. Lu X, Bing G, Hagg T. 2000. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Neuroscience 97:285-291.
23. Ma Q, Kinneer K. 2002. Chemoprotection by phenolic antioxidants: inhibition of tumor necrosis factor-α induction in macrophages. J Biol Chem 277:2477-2484.
24. Manal M, Mohsen AE, Kuhnle G, Rechner AR, Schroeter H, Rose S, Jenner P, Tice-Evans CA. 2002. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Rad Biol Med 33:1693-1702.
25. Mandel S, Weinreb O, Youdim MB. 2003. Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs. Trends Pharmacol Sci 14:13-20.
26. Mandel S, Weinreb O, Amit T, Youdim MB. 2004. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3- gallate: implications for neurodegenerative diseases. J Neurochem 88:1555-1569.
27. McGeer PL, Itagaki S, Boyes BE, McGeer EG. 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291.
28. McGeer PL, Yasojima K, McGeer EG. 2001. Inflammation in Parkinson's disease. Adv Neurol 86:83-89.
29. McMillian MK, Vainio PJ, Tuominen RK. 1997. Role of protein kinase C in microglia-induced neurotoxicity in mesencephalic cultures. J Neuropathol Exp Neurol 56:301-307.
30. Munch G, Gasic-Milenkovic J, Dukic-Stefanovic S, Kuhla B, Heinrich K, Riederer P, Huttunen HJ, Founds H, Sajithlal G. 2003. Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells. Exp Brain Res 150:1-8.
31. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. 2000. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13:49-54.
32. Nie GJ, Jin CF, Cao YL, Shen SG, Zhao BL. 2002. Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch Biochem Biophys 397:84-97.
33. Pan T, Jankovic J, Le WD. 2003. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging 20:711-721.
34. Sesso H, Gaziano J, Buring J, Hennekens C. 1999. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 149:162-167.
35. Sherer TB, Betarbet R, Kim JH, Greenamyre JT. 2003. Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci Lett 341:87-90.
36. Si QS, Nakamura Y, Kataoka K. 1997. Hypothermic suppression of microglial activation in culture: inhibition of cell proliferation and production of nitric oxide and superoxide. Neuroscience 81:223-229.
37. Siao CJ, Tsirka SE. 2002. Tissue plasminogen activator mediates microglial activation via its finger domain through Annexin II. J Neurosci 22:3352-3358.
38. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19:1771-1776.
39. Vila M, Jackson-Lewis V, Guegan C, Wu DC, Teismann P, Choi DK, Tieu K, Przedborski S. 2001. The role of glial cells in Parkinson's disease. Curr Opin Neurol 14:483-489.
40. Wang MJ, Lin WW, Chen HL, Chang YH, Ou HC, Kuo JS, Hong JS, Jeng KC. 2002. Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur J Neurosci 16:2103-2112.
41. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.
42. Yang C, Chung J, Yang G, Chhabra S, Lee M. 2000. Tea and tea polyphenols in cancer prevention. J Nutr 130:4725-4785.
43. Yang F, de Villiers WJ, McClain CJ, Varilek GW. 1998. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 128:2334-2340.